Darmadi, Darmadi, Taufik Sungkar, Cennikon Pakpahan, and Sem Samuel Surja. 2024. “An Efficacy and Safety Comparison of Regorafenib and Nivolumab in Unresectable Hepatocellular Cancer Patients: A Systematic Review”. Acta Medica Academica 53 (1):46-58. https://doi.org/10.5644/ama2006-124.443.